Cohanzick Management’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-151,907
Closed -$831K 52
2023
Q2
$831K Sell
151,907
-349,068
-70% -$2.07M 0.92% 34
2023
Q1
$3.1M Buy
500,975
+379,924
+314% +$1.7M 2.46% 9
2022
Q4
$452K Sell
121,051
-721,006
-86% -$3.01M 0.13% 107
2022
Q3
$3.6M Buy
842,057
+444,280
+112% +$1.89M 0.87% 32
2022
Q2
$1.5M Buy
397,777
+297,777
+298% +$2.34M 0.42% 67
2022
Q1
$988K Hold
100,000
0.22% 108
2021
Q4
$980K Buy
+100,000
New +$977K 0.17% 121

Other funds holding BTMD

Cohanzick Management's BTMD Position: Q3 2023 in Review

Cohanzick Management sold out of Biote Corp (BTMD) in Q3 2023, closing a stake of 151,907 shares — an estimated $831K sold.

Cohanzick Management first reported a position in BTMD in Q4 2021 and held it in 7 quarters. The position peaked at $3.6M in Q3 2022. 54 funds tracked by Wall St. Rank hold BTMD as of Q3 2023.

  • Cohanzick Management reported no remaining Biote Corp position as of Q3 2023 after selling out during the quarter.
  • Cohanzick Management sold 151,907 Biote Corp shares in Q3 2023, an estimated $831K.
  • Cohanzick Management first reported a position in Biote Corp in Q4 2021 and held it in 7 quarters.
  • Cohanzick Management's Biote Corp position peaked at $3.6M in Q3 2022.
  • 54 funds tracked by Wall St. Rank held Biote Corp as of Q3 2023.

Based on Cohanzick Management's 13F filing for Q3 2023, filed 14 Nov 2023.